The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23 and non-small cell lung cancer

Author(s):  
Serdar Arici
2015 ◽  
Vol 46 (12) ◽  
pp. 1821-1828 ◽  
Author(s):  
Juan Li ◽  
Zhaolong Wei ◽  
Hongyu Li ◽  
Qi Dang ◽  
Zongpu Zhang ◽  
...  

2015 ◽  
Vol 10 (7) ◽  
pp. 1083-1090 ◽  
Author(s):  
Liping Zhang ◽  
Hui Yu ◽  
Andrzej Badzio ◽  
Theresa A. Boyle ◽  
Hans-Ulrich Schildhaus ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document